IQVIA Stock Climbs 25% On A 5-Day Winning Streak
A multi-day run has sharply lifted the stock, prompting a closer look at the fundamental data supporting the move.
IQVIA (IQV) stock has now moved higher for 5 consecutive trading days, a run that produced a cumulative gain of 25%. The streak has added about $8.1 billion to the company’s market value, which now stands at about $41 billion.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry.
IQV Versus The S&P 500, Streak And Beyond
- Most Of GE Aerospace’s Return Has Not Come From The Market You Own
- SPMO ETF Hides A Heavy Tech Tilt
- IBM Swapped Its AI Scoreboard For A Quantum One
- Micron Stock Fell On China Worries As Customers Locked In Years Of Supply
- Why MELI Beats A Bond At Its Own Game
- Marvell Technology Stock: 5 Straight Red Days, Down 23%
Here is how IQV stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | IQV | S&P 500 |
|---|---|---|
| 1D | 1.9% | -1.5% |
| 5D (Current Streak) | 24.7% | -2.4% |
| 1M (21D) | 28.1% | -1.7% |
| 3M (63D) | 55.7% | 2.5% |
| YTD 2026 | 9.8% | 6.9% |
| 2025 | 14.7% | 16.4% |
| 2024 | -15.1% | 23.3% |
| 2023 | 12.9% | 24.2% |
The fundamentals offer a footing for the recent run.
The move appears to be specific to the company, as over the same 5 trading days the S&P 500 returned -2.4%. A look at the numbers shows a business growing slightly faster than the market median, with revenue over the last twelve months up 8.2% against the S&P 500 median of 7.8%. Its operating margin of 13.9% is below the median of 18.4%.
Investors are paying a price-to-earnings multiple of 29.9 for the stock, compared to an S&P 500 median of 24.4. While winning streaks are not uncommon, with 124 S&P 500 stocks currently on runs of three days or more, the magnitude of this move stands out.
A streak is information, not an instruction.
A persistent move in one direction is a clear signal of momentum and heightened investor attention. It is not, however, a signal to buy or sell. The disciplined approach is to use the new attention as a prompt to check the business fundamentals against the stock’s new price.
Streaks always end, but the underlying data on a company’s performance persists. The figures on growth, margins, and valuation provide a starting point for that work.
If you are hunting for strength that has more behind it than a hot tape, our Guidance Momentum screen surfaces the names where management raised its own outlook, which is the kind of momentum that tends to persist.
Prefer the theme to this single name? Our ETF Scorecard shows how the healthcare funds stack up. That way no single company’s next surprise decides the outcome.
Winning Streaks Are How Portfolios Get Concentrated
A stock that rises day after day quietly becomes a bigger share of the portfolio holding it. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.